USDA grants Medgene license to produce pig vaccines

Vaccines to target rotavirus, porcine circovirus, influenza A, and sapovirus
calendar icon 13 June 2023
clock icon 1 minute read

The USDA Center for Veterinary Biologics (CVB) has allowed animal health company, Medgene, license to produce and market a USDA-approved Platform Vaccine to the pork industry, the animal health care company said in a press release. The license applies to use of their Platform technology to produce vaccines addressing disease targets such as Rotavirus, Porcine Circovirus, Influenza A, and Sapovirus.

Medgene's vaccine approach leverages a USDA-approved "platform technology" that is safe and easily adapted to multiple animal disease targets. The result is the development of vaccines and an understanding of how diseases move across species and geographies in a fraction of the time of traditional vaccine approaches.

"Medgene's approach to Platform Vaccines allows us to keep our standards of animal health at the highest level possible," said Clayton Johnson, director of Veterinary Services for Carthage Veterinary Service, LTD.

Medgene announced their licensure on June 8 at the World Pork Expo, held on the Iowa State Fair fairgrounds, located in Des Moines, Iowa. 

"The pork industry's importance to our nation's food supply can't be overstated," said Medgene CEO Mark Luecke. "We've been working on getting the power of Platform technology into the hands of pork industry veterinarians for many years. Our license means we can bring the safety, speed, and value of this technology to work for the good of the industry."

© 2000 - 2024 - Global Ag Media. All Rights Reserved | No part of this site may be reproduced without permission.